Gene therapy of severe combined immunodeficiencies

Immunological Reviews

Volumn 178, Issue , 2000, Pages 13-20

  Fischer, Alain ^a,b   Hacein Bey, Salima ^a,b   Deist, Françoise Le ^a,b   Soudais, Claire ^a,b   Di Santo, James P ^a,b   De Basile, Geneviève Saint ^a,b   Cavazzana Calvo, Marina ^a,b  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DEAMINASE;

COMBINED IMMUNODEFICIENCY; ENZYME DEFICIENCY; GENE MUTATION; GENE THERAPY; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOGENETICS; LENTIVIRINAE; NONHUMAN; PRIORITY JOURNAL; REVIEW; TRANSGENE;

EID: 0034511449     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-065X.2000.17806.x     Document Type: Review

References (60)

1. European experience of bone-marrow transplantation for severe combined immunodeficiency
2. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency
3. Thymic function after hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency
4. Relationship between patterns of engraftment in peripheral blood and immune reconstitution after allogeneic bone marrow transplantation for (severe) combined immunodeficiency
5. Development of immunologic functions after bone marrow transplantation in 33 patients with severe combined immunodeficiency
6. Long-term chimerism and B-cell function after bone marrow transplantation in patients with severe combined immunodeficiency with B cells: A single-center study of 22 patients
7. Intrinsic defects of B cell function in X-linked severe combined immunodeficiency
8. Retroviral vectors
9. Identification of clonogenic common lymphoid progenitors in mouse bone marrow
10. The interleukin-2 receptor gamma chain: Its role in the multiple cytokine receptor complexes and T cell development in XSCID
11. Interleukin-2 receptor γ-chain mutation results in X-linked severe combined immunodeficiency in humans
12. The molecular basis of X-linked severe combined immunodeficiency: Defective cytokine receptor signaling
13. Atypical X-linked severe combined immunodeficiency due to possible spontaneous reversion of the genetic defect in T cells
14. Diversity, functionality, and stability of the T cell repertoire derived in vivo from a single human T cell precursor
15. Spontaneous in vivo reversion to normal of an inherited mutation in a patient with adenosine deaminase deficiency
16. c gene transfer into SCID X1 patients' B-cell lines restores normal high-affinity interleukin-2 receptor expression and function
17. Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells
18. Retroviral-mediated gene correction for X-linked severe combined immunodeficiency
19. Correction of interleukin-2 receptor function in X-SCID lymphoblastoid cells by retrovirally mediated transfer of the γ-c gene
20. Role of interleukin-2 (IL-2), IL-7, and IL-15 in natural killer cell differentiation from cord blood hematopoietic progenitor cells and from γc transduced severe combined immunodeficiency X1 bone marrow cells
21. - X-linked severe combined immunodeficiency hematopoietic progenitor cells in murine fetal thymic organ cultures
22. IL-2R gamma gene microdeletion demonstrates that canine X-linked severe combined immunodeficiency is a homologue of the human disease
23. Full immunologic reconstitution following nonconditioned bone marrow transplantation for canine X-linked severe combined immunodeficiency
24. Organization of the human CD40L gene: Implications for molecular defects in X chromosome-linked hyper-IgM syndrome and prenatal diagnosis
25. Restoration of lymphoid populations in a murine model of X-linked severe combined immunodeficiency by a gene-therapy approach
26. Stable and functional lymphoid reconstitution common cytokine receptor γ chain deficient mice by retroviral-mediated gene transfer
27. Restoration of lymphocyte function in Janus kinase 3-deficient mice by retroviral-mediated gene transfer
28. Virus-specific immunity after gene therapy in a murine model of severe combined immunodeficiency
29. Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells
30. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease
31. + cells in ADA-deficient SCID neonates
32. + severe combined immunodeficiency
33. Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID)
34. Mutation of Jak3 in a patient with SCID: Essential role of Jak3 in lymphoid development
35. Role of JAK3 in CD40-mediated signaling
36. RAG mutations in human B cell-negative SCID
37. Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency
38. Gene therapy in peripheral blood lymphocytes and bone marrow for ADA-immunodeficient patients
39. Bone marrow gene transfer in three patients with adenosine deaminase deficiency
40. ZAP-70 deficiency in an autosomal recessive form of severe combined immunodeficiency
41. Human severe combined immunodeficiency due to a defect in ZAP-70, a T cell tyrosine kinase
42. + thymic selection in humans lacking zap-70 kinase
43. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome)
44. A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome)
45. RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency
46. A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients
47. RFX-B is the gene responsible for the most common cause of the bare lymphocyte syndrome, an MHC class II immunodeficiency
48. Brief report: Primary immunodeficiency caused by mutations in the gene encoding the CD3-γ subunit of the T-lymphocyte receptor
49. Construction of retroviral vectors carrying human CD3 γ cDNA and reconstitution of CD3 γ expression and T cell receptor surface expression and function in a CD3 γ-deficient mutant T cell line
50. Independent mutations of the human CD3-epsilon gene resulting in a T cell receptor/CD3 complex immunodeficiency
51. -/- mice overtly react with self-major histocompatibility complex molecules upon restoration of normal surface density of T cell receptor-CD3 complex
52. Retroviral retargeting by envelopes expressing an N-terminal binding domain
53. Simultaneous infection with retroviruses pseudotyped with different envelope proteins bypasses viral receptor interference associated with colocalization of gp70 and target cells on fibronectin CH-296
54. Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus
55. Consistent, persistent expression from modified retroviral vectors in murine hematopoietic stem cells
56. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector
57. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo
58. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery
59. + cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors
60. - human hematopoietic cells by HIV-1-based lentiviral vectors